Women Want Strong Men
Revolutionizing Cancer Detection: The Power of a Single Blood Test with the Galleri Test - Dr. Whitney Jones
In this episode of the podcast, Dr. Whitney Jones, Grail's Senior Medical Advisor, joins us to discuss the Galleri cancer screening test. The Galleri test is a first-of-its-kind multi-cancer early detection test that can detect a signal shared by more than 50 cancer types and predict the tissue type or organ associated with the signal to help healthcare providers determine next steps.
The Galleri test is intended to complement routine single cancer screenings for more comprehensive early cancer detection. Routine screenings are recommended for certain patients for breast, cervical, colorectal, lung and prostate cancers.
Only screening for a single cancer does not effectively address the high prevalence of cancer given the probability of diagnosis for a specific cancer is uncertain, and the occurrence of individual cancers is relatively low. One in two men and one in three women are diagnosed with some form of cancer in America in their lifetime.
Some of the cancers that the Galleri test screens for include:
Adrenal Cortical Carcinoma
Ampulla of Vater
Anus
Appendix, Carcinoma
Bile Ducts, Distal
Bile Ducts, Intrahepatic
Bile Ducts, Perihilar
Bladder, Urinary
Bone
Breast
Cervix
Colon and Rectum
Esophagus and Esophagogastric Junction
Gallbladder
Gastrointestinal Stromal Tumor
Gestational Trophoblastic Neoplasms
Kidney
Larynx
Leukemia
Liver
Lung
Lymphoma (Hodgkin and Non-Hodgkin)
Melanoma of the Skin
Merkel Cell Carcinoma
Mesothelioma, Malignant Pleural
Nasal Cavity and Paranasal Sinuses Nasopharynx
Neuroendocrine Tumors of the Appendix
Neuroendocrine Tumors of the Colon and Rectum
Neuroendocrine Tumors of the Pancreas
Oral Cavity
Oropharynx (HPV-Mediated, p16+)
Oropharynx (p16-) and Hypopharynx
Ovary, Fallopian Tube and Primary Peritoneum
Pancreas, exocrine
Penis
Plasma Cell Myeloma and Plasma Cell Disorders
Prostate
Small Intestine
Soft Tissue Sarcoma of the Abdomen and Thoracic Visceral Organs
Soft Tissue Sarcoma of the Head and Neck
Soft Tissue Sarcoma of the Retroperitoneum
Soft Tissue Sarcoma of the Trunk and Extremities
Soft Tissue Sarcoma Unusual Histologies and Sites
Stomach
Testis
Ureter, Renal Pelvis
Uterus, Carcinoma and Carcinosarcoma
Uterus, Sarcoma
Vagina
Vulva
Studies:
REFLECTION is a multi-center, prospective, non-interventional, cohort study
The STRIVE Study: Development of a Blood Test for Early Detection of Multiple Cancer Types
This podcast is NOT medical advice.
Click to visit Grail's Website
Click here for Dr. Jones LinkedIn
Click to visit Victory Men's Health
Click to follow Amy Stuttle on Instagram
For questions please email podcast@amystuttle.com
In this episode of the podcast, Dr. Whitney Jones, Grail's Senior Medical Advisor, joins us to discuss the Galleri cancer screening test. The Galleri test is a first-of-its-kind multi-cancer early detection test that can detect a signal shared by more than 50 cancer types and predict the tissue type or organ associated with the signal to help healthcare providers determine next steps.
The Galleri test is intended to complement routine single cancer screenings for more comprehensive early cancer detection. Routine screenings are recommended for certain patients for breast, cervical, colorectal, lung and prostate cancers.
Only screening for a single cancer does not effectively address the high prevalence of cancer given the probability of diagnosis for a specific cancer is uncertain, and the occurrence of individual cancers is relatively low. One in two men and one in three women are diagnosed with some form of cancer in America in their lifetime.
Some of the cancers that the Galleri test screens for include:
Adrenal Cortical Carcinoma
Ampulla of Vater
Anus
Appendix, Carcinoma
Bile Ducts, Distal
Bile Ducts, Intrahepatic
Bile Ducts, Perihilar
Bladder, Urinary
Bone
Breast
Cervix
Colon and Rectum
Esophagus and Esophagogastric Junction
Gallbladder
Gastrointestinal Stromal Tumor
Gestational Trophoblastic Neoplasms
Kidney
Larynx
Leukemia
Liver
Lung
Lymphoma (Hodgkin and Non-Hodgkin)
Melanoma of the Skin
Merkel Cell Carcinoma
Mesothelioma, Malignant Pleural
Nasal Cavity and Paranasal Sinuses Nasopharynx
Neuroendocrine Tumors of the Appendix
Neuroendocrine Tumors of the Colon and Rectum
Neuroendocrine Tumors of the Pancreas
Oral Cavity
Oropharynx (HPV-Mediated, p16+)
Oropharynx (p16-) and Hypopharynx
Ovary, Fallopian Tube and Primary Peritoneum
Pancreas, exocrine
Penis
Plasma Cell Myeloma and Plasma Cell Disorders
Prostate
Small Intestine
Soft Tissue Sarcoma of the Abdomen and Thoracic Visceral Organs
Soft Tissue Sarcoma of the Head and Neck
Soft Tissue Sarcoma of the Retroperitoneum
Soft Tissue Sarcoma of the Trunk and Extremities
Soft Tissue Sarcoma Unusual Histologies and Sites
Stomach
Testis
Ureter, Renal Pelvis
Uterus, Carcinoma and Carcinosarcoma
Uterus, Sarcoma
Vagina
Vulva
Studies:
REFLECTION is a multi-center, prospective, non-interventional, cohort study
The STRIVE Study: Development of a Blood Test for Early Detection of Multiple Cancer Types
This podcast is NOT medical advice.
Click to visit Grail's Website
Click here for Dr. Jones LinkedIn
Click to visit Victory Men's Health
Click to follow Amy Stuttle on Instagram
For questions please email podcast@amystuttle.com